Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.29%
IXIC
-0.40%
FTSE
-0.42%
N225
+1.71%
AXJO
+0.73%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Key Stats

Market Cap
258.39M
Dividend Yield
0.00%
P/E Ratio
-2.11
EPS
-2.71
Revenue
-
Avg. Volume
1.21M

About

What does OMER do?
Omeros, a Seattle-based biopharmaceutical company with 198 employees, focuses on developing therapeutics for immunologic disorders and is advancing several candidates, including narsoplimab and OMS527, in clinical trials. The company went public on October 8, 2009.
Sector
💻 Health Care
IPO
CEO
Employees
202
Headquarters
Washington, USA
Website
http://www.omeros.com
Join our newsletter to keep up to date with us!

Recently from Cashu

publisher logo
Cashu

Omeros Corporation: Key Earnings Report Ahead, Spotlight on Narsoplimab and Innovation

3 days ago
publisher logo
Cashu

Omeros Corporation: Pioneering Biotech Innovations in Neurology and Inflammation Therapy

2 months ago
publisher logo
Cashu

Omeros Corporation: Pioneering Biotech Innovations with Strong Growth Potential

2 months ago
Stocks
Health Care
omer
Omeros
NASDAQ: OMER
+0.29 (+7.04%)
4.41
USD
At close at Aug 15, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials